M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells

References

• van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 2009; 56:430-42; PMID:19576682; http://dx.doi.org/10.1016/j.eururo.2009.06.028
   PubMed Web of Science ®Google Scholar
• Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27:289-93; PMID:19219610; http://dx.doi.org/10.1007/s00345-009-0383-3
   PubMed Web of Science ®Google Scholar
• Chan KS, Volkmer JP, Weissman I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol 2010; 20:393-97; PMID:20657288; http://dx.doi.org/10.1097/MOU.0b013e32833cc9df
   PubMed Web of Science ®Google Scholar
• Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int 2007; 72:1057-64; PMID:17667988; http://dx.doi.org/10.1038/sj.ki.5002439
   PubMed Web of Science ®Google Scholar
• Datta SN, Roosen A, Pullen A, Popat R, Rosenbaum TP, Elneil S, Dasgupta P, Fowler CJ, Apostolidis A. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders and changes with botulinum neurotoxin administration. The J Urol 2010; 184:2578-85; http://dx.doi.org/10.1016/j.juro.2010.07.034
   Web of Science ®Google Scholar
• Ochodnický P, Humphreys S, Eccles R, Poljakovic M, Wiklund P, Michel MC. Expression profiling of G-protein-coupled receptors in human urothelium and related cell lines. BJU Int 2012; 110:E293-E300; PMID:22551294; http://dx.doi.org/10.1111/j.1464-410X.2012.011145.x
   PubMedGoogle Scholar
• Nile CJ, Gillespie JI. Interactions between cholinergic and prostaglandin signaling elements in the urothelium: role of muscarinic type 2 receptors. Urol 2011; 79:e17-e23.
   Web of Science ®Google Scholar
• Braverman AS, Lebed B, Linder M, Ruggieri MR. M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors. Neurourol Urodyn 2007; 26:63-70; PMID:17123299; http://dx.doi.org/10.1002/nau.20378
   PubMed Web of Science ®Google Scholar
• Giglio D, Tobin G. Muscarinic receptor subtypes in the lower urinary tract. Pharmacology 2009; 83:259-69; PMID:19295256; http://dx.doi.org/10.1159/000209255
   PubMed Web of Science ®Google Scholar
• Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, Lips KS. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 2007; 80:2303-7; PMID:17335853; http://dx.doi.org/10.1016/j.lfs.2007.01.053
   PubMed Web of Science ®Google Scholar
• Arrighi N, Bodei S, Zani D, Michel MC, Simeone C, Cosciani Cunico S, Spano P, Sigala S. Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via AktPI3K and map kinases. Pharmacol Res 2013; 74:1-6; PMID:23628881; http://dx.doi.org/10.1016/j.phrs.2013.04.007
   PubMed Web of Science ®Google Scholar
• Kullmann FA, Artim D, Beckel J, Barrick S, de Groat WC, Birder LA. Heterogeneity of muscarinic receptor-mediated Ca2+ responses in cultured urothelial cells from rat. Am J Physiol Ren Physiol 2008; 294:971-81.
   Web of Science ®Google Scholar
• Kullmann FA, Artim DE, Birder LA, de Groat WC. Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci 2008; 28:1977-87; PMID:18287514; http://dx.doi.org/10.1523/JNEUROSCI.4694-07.2008
   PubMed Web of Science ®Google Scholar
• Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int 2007; 99:1433-8; PMID:17428242; http://dx.doi.org/10.1111/j.1464-410X.2007.06866.x
   PubMed Web of Science ®Google Scholar
• Mukerji G, Yiangou Y, Agarwal SK, Anand P. Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 2006; 176:797-801; PMID:16813950; http://dx.doi.org/10.1016/j.juro.2006.03.074
   PubMed Web of Science ®Google Scholar
• Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC, Birder LA. Non neuronal acetylcholine and urinary bladder urothelium. Life Sci 2007; 80:2298-302; PMID:17363007; http://dx.doi.org/10.1016/j.lfs.2007.02.010
   PubMed Web of Science ®Google Scholar
• Braverman AS. Alterations in muscarinic receptor subtype function in the bladder. Curr Bladder Dysf Rep 2009; 4:47-52; http://dx.doi.org/10.1007/s11884-009-0007-1
   Google Scholar
• Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. The prostate 1997; 30:160-66; PMID:9122040; http://dx.doi.org/10.1002/(SICI)1097-0045(19970215)30: 3<160::AID-PROS3>3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Frucht H, Jensen RT, Dexter D, Yang WL, Xiao Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clinical Cancer Res 1999; 5:2532-39.
   PubMed Web of Science ®Google Scholar
• Oppitz M, Möbus V, Brock S, Drews U. Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients. Gynecologic Oncol 2002; 85:159-64; http://dx.doi.org/10.1006/gyno.2002.6597
   PubMed Web of Science ®Google Scholar
• Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res 2007; 67:3936-42; PMID:17440109; http://dx.doi.org/10.1158/0008-5472.CAN-06-2484
   PubMed Web of Science ®Google Scholar
• Lammerding-Köppel M, Noda S, Blum A, Schaumburg-Lever G, Rassner G, Drews U. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas. J Cutan Pathol 1997; 24:137-44; PMID:9085148; http://dx.doi.org/10.1111/j.1600-0560.1997.tb01567.x
   PubMed Web of Science ®Google Scholar
• Fiszman GL, Sales ME. Antibodies against muscarinic receptors in breast cancer: Agonizing tumor growth. Curr Immunol 2008; 4:1-7.
   Google Scholar
• Boss A, Oppitz M, Drews U. Muscarinic cholinergic receptors in the human melanoma cell line SK-Mel 28: modulation of chemotaxis. Clin Exp Dermatol 2005; 30:557-64; PMID:16045692; http://dx.doi.org/10.1111/j.1365-2230.2005.01865.x
   PubMed Web of Science ®Google Scholar
• Rimmaudo LE, de la Torre E, Sacerdote de Lustig E, Sales ME. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. Bioch. Bioph. Res. Com 2005; 334:1359-136.
   PubMed Web of Science ®Google Scholar
• Song P, Sekhon HS, Proskocil B, Blusztajn JK, Mark GP, Spindel ER. Synthesis of acetylcholine by lung cancer. Life Sci 2003; 19:2159-68; http://dx.doi.org/10.1016/S0024-3205(03)00078-X
   Web of Science ®Google Scholar
• Ferretti M, Fabbiano C, Di Bari M, Ponti D, Calogero A, Tata AM. M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines. Life Sci 2012; 91:1134-37; PMID:22575825; http://dx.doi.org/10.1016/j.lfs.2012.04.033
   PubMed Web of Science ®Google Scholar
• Ferretti M, Fabbiano C, Di Bari M, Conte C, Castigli E, Sciaccaluga M, Ponti D, Ruggieri P, Raco A, Ricordy R, Calogero A, Tata AM. M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells. J Cell Mol Med 2013; 17:552-66; PMID:23490231; http://dx.doi.org/10.1111/jcmm.12038
   PubMed Web of Science ®Google Scholar
• Greig NH, Reale M, Tata AM. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors. Recent Pat CNS Drug Discov 2013; 8:123-41; PMID:23597304; http://dx.doi.org/10.2174/1574889811308020003
   PubMedGoogle Scholar
• Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004; 294:534-49; PMID:15023540; http://dx.doi.org/10.1016/j.yexcr.2003.12.010
   PubMed Web of Science ®Google Scholar
• Bordey A, Sontheimer H, Trouslard J. Muscarinic activation of BK channels induces membrane oscillations in glioma cells and leads to inhibition of cell migration. J Membr Biol 2000; 176:31-40; PMID:10882426; http://dx.doi.org/10.1007/s002320001073
   PubMed Web of Science ®Google Scholar
• Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 2009; 296:C221-C232; PMID:19036940
   PubMed Web of Science ®Google Scholar
• Tully BT, Li M, Sun Y, Berkowitz J, Chai TC. Defects in muscarinic receptor cell signalling in bladder urothelial cancer cell lines. Urology 2009; 74:467-73; PMID:19573899; http://dx.doi.org/10.1016/j.urology.2009.02.043
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Kanai A. Urotheliogenic modulation of intrinsic activity in spinal cord-transected rat bladders: role of mucosal muscarinic receptors. Am J Physiol Renal Physiol 2008; 295:F454-F461. x; PMID:18550643
   PubMed Web of Science ®Google Scholar
• Ehsani L, Osunkoya AO. Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters. Int J Clin Exp Pathol 2014; 7(5):2544-50; PMID:24966967
   PubMed Web of Science ®Google Scholar
• Barlow RB and Weston-Smith P. The relative potencies of some agonists at M2 muscarinic receptors in guinea-pig ileum, atria and bronchi. Br J Pharmacol 1985; 85:437-40; PMID:3896364; http://dx.doi.org/10.1111/j.1476-5381.1985.tb08879.x
   PubMed Web of Science ®Google Scholar
• Loreti S, Ricordy R, De Stefano ME, Augusti-Tocco G, Tata AM. Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype. Neuron Glia Biol 2007; 3:269-79; PMID:18634559; http://dx.doi.org/10.1017/S1740925X08000045
   PubMed Web of Science ®Google Scholar
• De Angelis F, Bernardo A, Magnaghi V, Minghetti L, Tata AM. Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation and differentiation. Dev. Neurobiol 2012; 72:713-28; PMID:21913336; http://dx.doi.org/10.1002/dneu.20976
   PubMed Web of Science ®Google Scholar
• x Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 2005; 12:709-16; PMID:16174043
   PubMed Web of Science ®Google Scholar
• Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Hinoda Y, Dahiya R. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by down-regulating RhoC and FZD4. Mol Cancer Ther 2012; 11:244-53; PMID:22057916; http://dx.doi.org/10.1158/1535-7163.MCT-11-0592
   PubMed Web of Science ®Google Scholar
• Coccia A, Bastianelli D, Mosca L, Monticolo R, Panuccio I, Carbone A, Calogero A, Lendaro E. Extra Virgin Olive Oil Phenols Suppress Migration and Invasion of T24 Human Bladder Cancer Cells Through Modulation of Matrix Metalloproteinase-2. Nutr Cancer 2014 Jun 11:1-9; http://dx.doi.org/10.108001635581.2014.922204
   Web of Science ®Google Scholar
• De Falco E, Scafetta G, Napoletano C, Puca R, Vingolo EM, Ragona G, Iorio O, Frati G. A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts. Cell Tissue Banking 2013; 14:277-87; PMID:22820760; http://dx.doi.org/10.1007/s10561-012-9325-1
   PubMed Web of Science ®Google Scholar
• Scafetta G, Tricoli E, Siciliano C, Napoletano C, Puca R, Vingolo EM, Cavallaro G, Polistena A, Frati G, De Falco E. Suitability of Human Tenon's Fibroblasts as Feeder Cells for Culturing Human Limbal Epithelial Stem Cells. Stem Cell Rev 2013, 9:847-57; PMID:23832306; http://dx.doi.org/10.1007/s12015-013-9451-6
   PubMed Web of Science ®Google Scholar
• Menna C, De Falco E, Pacini L, Scafetta G, Ruggieri P, Puca R, Petrozza V, Ciccone AM, Rendina EA, Calogero A, Ibrahim M. Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture. Cancer Invest 2014; 32:13-21; PMID:24380379; http://dx.doi.org/10.3109/07357907.2013.861472
   PubMed Web of Science ®Google Scholar